The leptin-receptor may predict poor patient prognosis in the AGC, Lauren diffuse and lymph node metastasis subgroups, while EBV-positive status can show a good prognosis in the AGC. The gene discussed is LEPR; the disease is metastatic malignant neoplasm in the lymph nodes.